Advertisement

Topics

Ex-GSK, Novartis exec named as Mundipharma's Head of Access http://bit.ly/2E7RXMp  #pharmapic.twitter.com/uCCbtpeMy5

12:29 EDT 14 May 2019 | Pharmafile

Ex-GSK, Novartis exec named as Mundipharma's Head of Access http://bit.ly/2E7RXMp 

Original Article: Ex-GSK, Novartis exec named as Mundipharma's Head of Access http://bit.ly/2E7RXMp  #pharmapic.twitter.com/uCCbtpeMy5

NEXT ARTICLE

More From BioPortfolio on "Ex-GSK, Novartis exec named as Mundipharma's Head of Access http://bit.ly/2E7RXMp  #pharmapic.twitter.com/uCCbtpeMy5"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...